Evaluating futility of a binary clinical endpoint using early read-outs

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Drug Development

Background:

• Interim analyses are crucial for monitoring clinical trial data and enabling early cessation for futility.
• Challenges arise in trials with long follow-up periods, where primary endpoint data is often unavailable for early interim analyses.
• Existing methods for interim analyses, especially those using predictive short-term endpoints, can perform poorly with scarce data or imperfect predictors.

Purpose of the Study:

• To develop a robust interim decision procedure for clinical trials that facilitates early futility stopping.
• To create a method that effectively utilizes both short-term predictive and long-term primary endpoints.
• To address limitations of existing methods, particularly in scenarios with limited patient data or imperfect predictive endpoints.

Main Methods:

• Development of an interim decision procedure based on the conditional power approach.
• Integration of short-term and long-term binary endpoints within a unified framework.
• Incorporation of historical information to improve inference reliability.

Main Results:

• The proposed procedure is designed to provide reliable inferences even with a small number of patients having observed primary endpoint data.
• It is expected to perform better than existing tests when data is scarce or the short-term endpoint is an imperfect predictor.
• Operational characteristics were evaluated using simulation studies, particularly for a motivating phase III clinical trial.

Conclusions:

• The developed interim decision procedure offers a reliable approach for early futility stopping in clinical trials.
• It effectively leverages predictive short-term endpoints and historical data, enhancing decision-making under data scarcity.
• This method improves upon existing techniques by providing more stable inferences when primary endpoint data is limited.